Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease—A Systematic Review

Abstract

This review provides an up-to-date literature account on the efficacy of Botulinum toxin treatment for common motor disorders of Parkinson Disease. The reviewed disorders include the common motor disorders in PD such as tremor, focal foot dystonia, rigidity and freezing of gait (FOG). In the area of Parkinson tremor, two newly described evaluation/injection techniques (Yale method in USA and Western University method in Canada) offer efficacy with low incidence of hand and finger weakness as side effects. Blinded studies conducted on foot dystonia of PD indicate that botulinum toxin injections into toe flexors are efficacious in alleviating this form of dystonia. Small, blinded studies suggest improvement of Parkinson rigidity after botulinum toxin injection; proof of this claim, however, requires information from larger, blinded clinical trials. In FOG, the improvement reported in open label studies could not be substantiated in blinded investigations. However, there is room for further controlled studies that include the proximal lower limb muscles in the injection plan and/or use higher doses of the injected toxin for this indication.

Use of botulinum toxin in the management of dystonia in Parkinson’s disease

“…This property has been used for therapeutic purposes, including in the treatment of dystonia. There are many indications for BoNT in patients with PD and other parkinsonian disorders ( Jankovic, 2009 ; Cardoso, 2018 ; Jost, 2021 ; Lapostolle et al, 2022 ; Anandan and Jankovic, 2023 ; Jabbari and Comtesse, 2023 ). This article will focus on the use of BoNT in PD-associated dystonia.…”